New Delhi, Aug 13 (IANS) India’s scientific and technological landscape is rapidly pacing toward global leadership, according to a report.
New Delhi, Aug 13 (IANS) India's tier 2 and Tier 3 cities currently account for only 6 per cent of the country's data centre capacity or approximately 82 MW, but by 2030, that number is expected to rise to 300–400 MW, according to latest reports.
New Delhi, Aug 13 (IANS) The Reserve Bank of India (RBI) may implement a 25 basis point rate cut in the fourth quarter this year if moderate high-frequency data from June continues, a report said on Wednesday.
New Delhi, Aug 13 (IANS) A Crisil report on Wednesday projected India’s headline inflation to average 3.5 per cent this fiscal (FY26) from 4.6 per cent in the last, as healthy agricultural production is expected to keep food inflation in check.
New Delhi, Aug 13 (IANS) Tech giant Apple has denied any foul play, insisting its platform is “fair and free of bias" after Tesla and SpaceX owner Elon Musk accused the iPhone maker of favouritism in App Store rankings.
New Delhi, Aug 13 (IANS) The India-UK Comprehensive Economic and Trade Agreement (CETA) is set to benefit the domestic mineral sector, according to the Ministry of Mines.
Mumbai, Aug 13 (IANS) The Indian benchmark indices opened higher on Wednesday, after the US inflation data raised expectations of a Federal Reserve rate cut.
New Delhi, Aug 13 (IANS) As August inflation print likely to top 2 per cent and be closer to 2.3 per cent, a rate cut by the Reserve Bank of India (RBI) in October looks difficult, SBI Research said on Wednesday, adding that even a rate cut in December looks a tad difficult if growth numbers for Q1 and Q2 are taken into consideration.
New Delhi, Aug 12 (IANS) Farmers from across the country lauded Prime Minister Narendra Modi for his bold decision in trade agreements despite foreign pressure, expressing their gratitude towards him for his farmer-friendly historic decision.
New Delhi, Aug 12 (IANS) The Indian pharma sector, which supplies 80 per cent of the world's generic medicines, will not suffer any loss due to tariffs imposed by US President Donald Trump, the ICMR's former Director General, Dr N.K. Ganguly said.
